Cargando…
Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study
BACKGROUND: A humanitarian emergency involves a complete breakdown of authority that often disrupts routine health care delivery, including immunization. Diarrheal diseases are a principal cause of morbidity and mortality among children during humanitarian emergencies. The objective of this study wa...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331177/ https://www.ncbi.nlm.nih.gov/pubmed/25691915 http://dx.doi.org/10.1186/s13031-015-0032-y |
_version_ | 1782357677237600256 |
---|---|
author | Gargano, Lisa M Tate, Jacqueline E Parashar, Umesh D Omer, Saad B Cookson, Susan T |
author_facet | Gargano, Lisa M Tate, Jacqueline E Parashar, Umesh D Omer, Saad B Cookson, Susan T |
author_sort | Gargano, Lisa M |
collection | PubMed |
description | BACKGROUND: A humanitarian emergency involves a complete breakdown of authority that often disrupts routine health care delivery, including immunization. Diarrheal diseases are a principal cause of morbidity and mortality among children during humanitarian emergencies. The objective of this study was to assess if vaccination against rotavirus, the most common cause of severe diarrhea among children, either as an addition to routine immunization program (RI) or supplemental immunization activity (SIA) would be cost-effective during a humanitarian emergency to decrease diarrhea morbidity and mortality, using Somalia as a case study. METHODS: An impact and cost-effectiveness analysis was performed comparing no vaccine; two-dose rotavirus SIA and two-dose of RI for the 424,592 births in the 2012 Somali cohort. The main summary measure was the incremental cost per disability-adjusted life-year (DALY) averted. Univariate sensitivity analysis examined the extent to which the uncertainty in the variables affected estimates. RESULTS: If introduced in Somalia, a full-series rotavirus RI and SIA would save 908 and 359 lives, respectively, and save US$63,793 and US$25,246 in direct medical costs, respectively. The cost of a RI strategy would be US$309,458. Because of the high operational costs, a SIA strategy would cost US$715,713. US$5.30 per DALY would be averted for RI and US$37.62 per DALY averted for SIA. Variables that most substantially influenced the cost-effectiveness for both RI and SIA were vaccine program costs, mortality rate, and vaccine effectiveness against death. CONCLUSIONS: Based on our model, rotavirus vaccination appears to be a cost-effective intervention as either RI or SIA, as defined by the World Health Organization as one to three times the per capita Gross Domestic Product (Somalia $112 in 2011). RI would have greater health impact and is more cost effective than SIA, assuming feasibility of reaching the target population. However, given the lack of infrastructure, whether RI is realistic in this setting remains unanswered, and alternative approaches like SIA should be further examined. |
format | Online Article Text |
id | pubmed-4331177 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43311772015-02-18 Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study Gargano, Lisa M Tate, Jacqueline E Parashar, Umesh D Omer, Saad B Cookson, Susan T Confl Health Research Article BACKGROUND: A humanitarian emergency involves a complete breakdown of authority that often disrupts routine health care delivery, including immunization. Diarrheal diseases are a principal cause of morbidity and mortality among children during humanitarian emergencies. The objective of this study was to assess if vaccination against rotavirus, the most common cause of severe diarrhea among children, either as an addition to routine immunization program (RI) or supplemental immunization activity (SIA) would be cost-effective during a humanitarian emergency to decrease diarrhea morbidity and mortality, using Somalia as a case study. METHODS: An impact and cost-effectiveness analysis was performed comparing no vaccine; two-dose rotavirus SIA and two-dose of RI for the 424,592 births in the 2012 Somali cohort. The main summary measure was the incremental cost per disability-adjusted life-year (DALY) averted. Univariate sensitivity analysis examined the extent to which the uncertainty in the variables affected estimates. RESULTS: If introduced in Somalia, a full-series rotavirus RI and SIA would save 908 and 359 lives, respectively, and save US$63,793 and US$25,246 in direct medical costs, respectively. The cost of a RI strategy would be US$309,458. Because of the high operational costs, a SIA strategy would cost US$715,713. US$5.30 per DALY would be averted for RI and US$37.62 per DALY averted for SIA. Variables that most substantially influenced the cost-effectiveness for both RI and SIA were vaccine program costs, mortality rate, and vaccine effectiveness against death. CONCLUSIONS: Based on our model, rotavirus vaccination appears to be a cost-effective intervention as either RI or SIA, as defined by the World Health Organization as one to three times the per capita Gross Domestic Product (Somalia $112 in 2011). RI would have greater health impact and is more cost effective than SIA, assuming feasibility of reaching the target population. However, given the lack of infrastructure, whether RI is realistic in this setting remains unanswered, and alternative approaches like SIA should be further examined. BioMed Central 2015-02-09 /pmc/articles/PMC4331177/ /pubmed/25691915 http://dx.doi.org/10.1186/s13031-015-0032-y Text en © Gargano et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Gargano, Lisa M Tate, Jacqueline E Parashar, Umesh D Omer, Saad B Cookson, Susan T Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study |
title | Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study |
title_full | Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study |
title_fullStr | Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study |
title_full_unstemmed | Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study |
title_short | Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study |
title_sort | comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, somali case study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331177/ https://www.ncbi.nlm.nih.gov/pubmed/25691915 http://dx.doi.org/10.1186/s13031-015-0032-y |
work_keys_str_mv | AT garganolisam comparisonofimpactandcosteffectivenessofrotavirussupplementaryandroutineimmunizationinacomplexhumanitarianemergencysomalicasestudy AT tatejacquelinee comparisonofimpactandcosteffectivenessofrotavirussupplementaryandroutineimmunizationinacomplexhumanitarianemergencysomalicasestudy AT parasharumeshd comparisonofimpactandcosteffectivenessofrotavirussupplementaryandroutineimmunizationinacomplexhumanitarianemergencysomalicasestudy AT omersaadb comparisonofimpactandcosteffectivenessofrotavirussupplementaryandroutineimmunizationinacomplexhumanitarianemergencysomalicasestudy AT cooksonsusant comparisonofimpactandcosteffectivenessofrotavirussupplementaryandroutineimmunizationinacomplexhumanitarianemergencysomalicasestudy |